ArticleChest2014
Counterpoint: were industry-sponsored roflumilast trials appropriate? No.
Jason Rho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleChest2014
Jason Rho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.